- Home
- TURN vs HOOK Comparison
TURN vs HOOK Comparison
Compare TURN & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- HOOK
- Stock Information
- Founded
- TURN 1981
- HOOK 2011
- Country
- TURN United States
- HOOK United States
- Employees
- TURN N/A
- HOOK N/A
- Industry
- TURN Finance/Investors Services
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- TURN Finance
- HOOK Health Care
- Exchange
- TURN Nasdaq
- HOOK Nasdaq
- Market Cap
- TURN 35.7M
- HOOK 30.2M
- IPO Year
- TURN N/A
- HOOK 2019
- Fundamental
- Price
- TURN $3.65
- HOOK $2.00
- Analyst Decision
- TURN
- HOOK Strong Buy
- Analyst Count
- TURN 0
- HOOK 4
- Target Price
- TURN N/A
- HOOK $34.50
- AVG Volume (30 Days)
- TURN 37.2K
- HOOK 66.7K
- Earning Date
- TURN 08-19-2024
- HOOK 11-14-2024
- Dividend Yield
- TURN N/A
- HOOK N/A
- EPS Growth
- TURN N/A
- HOOK N/A
- EPS
- TURN N/A
- HOOK N/A
- Revenue
- TURN $129,297.00
- HOOK $49,999,000.00
- Revenue This Year
- TURN N/A
- HOOK $147.52
- Revenue Next Year
- TURN N/A
- HOOK N/A
- P/E Ratio
- TURN N/A
- HOOK N/A
- Revenue Growth
- TURN 6.32
- HOOK 143.30
- 52 Week Low
- TURN $3.12
- HOOK $1.88
- 52 Week High
- TURN $4.47
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- TURN 55.40
- HOOK 26.63
- Support Level
- TURN $3.61
- HOOK $2.01
- Resistance Level
- TURN $3.75
- HOOK $2.27
- Average True Range (ATR)
- TURN 0.11
- HOOK 0.18
- MACD
- TURN -0.01
- HOOK 0.02
- Stochastic Oscillator
- TURN 42.86
- HOOK 31.94
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.